Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
NOROO PAINT & COATINGS Co., Ltd. (090350.KS)
KRW7,540.00
+140.00 (+1.89%)
KR KSC Basic Materials Chemicals - Specialty
Address
351, Bakdal-ro
Anyang-Si, KR
Anyang-Si, KR
CEO
Sung-Kug Cho
Website
noroopaint.com
IPO
2006-07-03
ISIN KR7090350000
Also trades on
Korea Exchange · 090350.KS (KRW)
Korea Exchange · 090355.KS (KRW)
Description
NOROO PAINT & COATINGS Co., Ltd. operates as a global entity, developing, producing, and distributing a wide array of paint products across South Korea and international markets. Its extensive portfolio includes specialized coatings for floors, waterproofing solutions, heavy-duty industrial applications, Pre-Coated Metal (PCM), and general industrial use, as well as paints for architectural projects and automotive refinishing. Beyond manufacturing, the company also engages in market research, fostering industry connections, paint material trading, and offering design research and consulting services. Established in 1945, the firm is headquartered in Anyang-si, South Korea, and functions as a subsidiary of NOROO Holdings Co., Ltd.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
KRW7,540.00
+140.00 (+1.89%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
104.4K
Beta
0.52
Float Shares
9.57M
Free Float %
47.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.89% | -5.70% | -11.89% | -12.29% | -5.01% | -7.49% | -13.75% | -9.22% | -41.06% | -26.95% | +44.07% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
7,540.00
DCF (Unlevered)
59,628.81
+690.8%
DCF (Levered)
69,193.31
+817.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.34
Grey zone
Piotroski F-Score
6 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
A
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
2 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Chemicals - Specialty: +4.7%-2.9% Q1'26: +2.4% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-53.2% Q1'26: +102.9% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+2.2% Q1'26: -7.8% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+3.9% Q1'26: +4.6% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+4.9% Q1'26: +6.1% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×1.56× ★ Q1'26: 1.50× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
461.65B
est: 459.30B (+0.5%)
|
478.94B
est: 477.70B (+0.3%)
|
551.41B
est: 520.70B (+5.9%)
|
614.73B
est: 623.10B (-1.3%)
|
647.45B
est: 647.50B (0.0%)
|
642.94B
est: 666.90B (-3.6%)
|
730.93B
est: 693.60B (+5.4%)
|
793.85B
est: 477.70B (+66.2%)
|
771.05B
est: 477.70B (+61.4%)
|
520.70B
520.70B – 520.70B
+9.0% YoY
|
623.10B
623.10B – 623.10B
+19.7% YoY
|
647.50B
647.50B – 647.50B
+3.9% YoY
|
666.90B
666.90B – 666.90B
+3.0% YoY
|
693.60B
693.60B – 693.60B
+4.0% YoY
|
| EBITDA |
41.59B
est: 29.75B (+39.8%)
|
38.21B
est: 30.94B (+23.5%)
|
57.19B
est: 33.73B (+69.6%)
|
37.31B
est: 40.36B (-7.5%)
|
45.41B
est: 41.94B (+8.3%)
|
46.64B
est: 43.20B (+8.0%)
|
44.19B
est: 44.93B (-1.7%)
|
57.79B
est: 33.47B (+72.7%)
|
45.40B
est: 33.47B (+35.6%)
|
36.49B
36.49B – 36.49B
+9.0% YoY
|
43.66B
43.66B – 43.66B
+19.7% YoY
|
45.37B
45.37B – 45.37B
+3.9% YoY
|
46.73B
46.73B – 46.73B
+3.0% YoY
|
48.60B
48.60B – 48.60B
+4.0% YoY
|
| EBIT |
47.87B
est: 20.43B (+134.3%)
|
27.91B
est: 21.25B (+31.3%)
|
44.90B
est: 23.17B (+93.8%)
|
24.10B
est: 27.72B (-13.1%)
|
30.71B
est: 28.81B (+6.6%)
|
31.24B
est: 29.67B (+5.3%)
|
29.23B
est: 30.86B (-5.3%)
|
43.37B
est: 24.91B (+74.1%)
|
30.18B
est: 24.91B (+21.1%)
|
27.16B
27.16B – 27.16B
+9.0% YoY
|
32.50B
32.50B – 32.50B
+19.7% YoY
|
33.77B
33.77B – 33.77B
+3.9% YoY
|
34.78B
34.78B – 34.78B
+3.0% YoY
|
36.17B
36.17B – 36.17B
+4.0% YoY
|
| Net Income |
32.74B
est: 34.59B (-5.4%)
|
9.50B
est: 12.90B (-26.3%)
|
29.44B
est: 16.99B (+73.3%)
|
12.74B
est: 19.43B (-34.4%)
|
18.90B
est: 18.91B (-0.1%)
|
17.98B
est: 32.63B (-44.9%)
|
14.45B
est: 34.72B (-58.4%)
|
35.17B
est: 12.90B (+172.7%)
|
16.46B
est: 12.90B (+27.6%)
|
16.99B
16.99B – 16.99B
+31.7% YoY
|
19.43B
19.43B – 19.43B
+14.3% YoY
|
18.91B
18.91B – 18.91B
-2.6% YoY
|
32.63B
32.63B – 32.63B
+72.5% YoY
|
34.72B
34.72B – 34.72B
+6.4% YoY
|
| SGA |
44.58B
est: 33.29B (+33.9%)
|
46.91B
est: 34.62B (+35.5%)
|
46.14B
est: 37.74B (+22.3%)
|
50.31B
est: 45.16B (+11.4%)
|
51.28B
est: 46.93B (+9.3%)
|
55.34B
est: 48.34B (+14.5%)
|
48.89B
est: 50.27B (-2.7%)
|
57.11B
est: 33.56B (+70.2%)
|
58.56B
est: 33.56B (+74.5%)
|
36.58B
36.58B – 36.58B
+9.0% YoY
|
43.78B
43.78B – 43.78B
+19.7% YoY
|
45.49B
45.49B – 45.49B
+3.9% YoY
|
46.85B
46.85B – 46.85B
+3.0% YoY
|
48.73B
48.73B – 48.73B
+4.0% YoY
|
| EPS |
1,600.00
est: 1,690.00 (-5.3%)
|
464.00
est: 630.00 (-26.3%)
|
1,439.00
est: 830.00 (+73.4%)
|
623.00
est: 949.00 (-34.4%)
|
923.60
est: 924.00 (0.0%)
|
878.73
est: 1,594.00 (-44.9%)
|
705.94
est: 1,696.00 (-58.4%)
|
1,718.00
est: 630.00 (+172.7%)
|
804.00
est: 630.00 (+27.6%)
|
830.00
830.00 – 830.00
+31.7% YoY
|
949.00
949.00 – 949.00
+14.3% YoY
|
924.00
924.00 – 924.00
-2.6% YoY
|
1,594.00
1,594.00 – 1,594.00
+72.5% YoY
|
1,696.00
1,696.00 – 1,696.00
+6.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-28 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-27 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-06 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-04 | A | 4/5 | 5/5 | 3/5 | 4/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-23 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-22 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-21 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-20 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-17 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-16 | A | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
8.31B
OE per share TTM
405.29
Owner's Yield
5.22%
Maintenance CapEx ratio
1.66%
Maint CapEx / Avg PPE
39.7%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 6 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Kodex KOSPI 226490.KS | 0.00% | 31.2K | 0.15% |
| 2 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 33.7K | 0.46% |
| 3 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 63.3K | 0.39% |
| 4 | Dimensional - Emerging Core Equity Market ETF DFAE | 0.00% | 48.4K | 0.29% |
| 5 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 41.9K | 0.28% |
| 6 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.00% | 197.58 | 0.56% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
38.79M
Shares Outstanding
20.00M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jun-seo Song | MD & Director | — | male |
| Sung-Kug Cho | President, Chief Executive Officer & Director | — | male |
| Won-Seok Han | Executive Director | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 090350.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
